Upgrade to SI Premium - Free Trial

Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results

July 27, 2016 10:58 AM
Brean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles